Tue, March 6, 2012
Mon, March 5, 2012
[ Mon, Mar 05th 2012 ] - Market Wire
Sienna Gold Warrants Extended
[ Mon, Mar 05th 2012 ] - Market Wire
30 a.m. ET
Fri, March 2, 2012
Thu, March 1, 2012
Wed, February 29, 2012
Tue, February 28, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
Alere to Acquire eScreen, Inc.
[ Tue, Feb 28th 2012 ] - Market Wire
ICON Acquires PriceSpective
Mon, February 27, 2012
Sat, February 25, 2012
Fri, February 24, 2012
[ Fri, Feb 24th 2012 ] - Market Wire
BrainStorm Featured on CNBC
Thu, February 23, 2012
[ Thu, Feb 23rd 2012 ] - Market Wire
00 am ET
Wed, February 22, 2012
Tue, February 21, 2012

Quest Diagnostics Declares Quarterly Cash Dividend


//health-fitness.news-articles.net/content/2012/ .. iagnostics-declares-quarterly-cash-dividend.html
Published in Health and Fitness on Tuesday, February 28th 2012 at 12:26 GMT by Market Wire   Print publication without navigation


Quest Diagnostics Declares Quarterly Cash Dividend -- MADISON, N.J., Feb. 28, 2012 /PRNewswire/ --

Quest Diagnostics Declares Quarterly Cash Dividend

[ ]

MADISON, N.J., Feb. 28, 2012 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: [ DGX ]), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.17 per share, payable on April 17, 2012, to shareholders of record of Quest Diagnostics common stock on April 3, 2012.

About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at [ QuestDiagnostics.com ]. Follow us at Facebook.com/QuestDiagnostics and Twitter.com/QuestDX.

Quest Diagnostics Contacts:
Kathleen Valentine (Investors): 973-520-2900
Wendy Bost (Media): 973-520-2800

SOURCE Quest Diagnostics Incorporated

[ Back to top ]

RELATED LINKS
[ http://www.questdiagnostics.com ]


Publication Contributing Sources